{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:00:44Z","timestamp":1769554844320,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11657-021-00982-x","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T08:03:24Z","timestamp":1627977804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Vitamin D deficiency is a risk factor for new fractures in Japanese postmenopausal women with rheumatoid arthritis: results from the IORRA cohort study"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6757-897X","authenticated-orcid":false,"given":"Masanori","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7771-2813","authenticated-orcid":false,"given":"Takefumi","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-7769","authenticated-orcid":false,"given":"Eisuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2850-326X","authenticated-orcid":false,"given":"Eiichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9066-2005","authenticated-orcid":false,"given":"Katsunori","family":"Ikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8453-6731","authenticated-orcid":false,"given":"Hisashi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-2603","authenticated-orcid":false,"given":"Masayoshi","family":"Harigai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"key":"982_CR1","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00198-014-2911-2","volume":"26","author":"K Ochi","year":"2015","unstructured":"Ochi K, Inoue E, Furuya T, Ikari K, Toyama Y, Taniguchi A, Yamanaka H, Momohara S (2015) Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture. Osteoporos Int 26:961\u2013968","journal-title":"Osteoporos Int"},{"key":"982_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00774-016-0805-4","volume":"35","author":"R Okazaki","year":"2017","unstructured":"Okazaki R, Ozono K, Fukumoto S, Inoue D, Yamauchi M, Minagawa M, Michigami T, Takeuchi Y, Matsumoto T, Sugimoto T (2017) Assessment criteria for vitamin D deficiency\/insufficiency in Japan: proposal by an expert panel supported by the Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society [Opinion]. J Bone Miner Metab 35:1\u20135","journal-title":"J Bone Miner Metab"},{"key":"982_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bone.2007.11.002","volume":"42","author":"NM van Schoor","year":"2008","unstructured":"van Schoor NM, Visser M, Pluijm SMF, Kuchuk N, Smit JH, Lips P (2008) Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone 42:260\u2013266","journal-title":"Bone"},{"key":"982_CR4","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1002\/jbmr.449","volume":"6","author":"JA Cauley","year":"2011","unstructured":"Cauley JA, Danielson ME, Boudreau R, Barbour KE, Horwitz MJ, Bauer DC, Ensrud KE, Manson JE, Wactawski-Wende J, Shikany JM, Jackson RD (2011) Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the Women\u2019s Health Initiative (WHI). J Bone Miner Res 6:2378\u20132388","journal-title":"J Bone Miner Res"},{"key":"982_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00198-010-1213-6","volume":"22","author":"K Nakamura","year":"2011","unstructured":"Nakamura K, Saito T, Oyama M, Oshiki R, Kobayashi R, Nishiwaki T, Nashimoto M, Tsuchiya Y (2011) Vitamin D sufficiency is associated with low incidence of limb and vertebral fractures in community-dwelling elderly Japanese women: the Muramatsu Study. Osteoporos Int 22:97\u2013103","journal-title":"Osteoporos Int"},{"key":"982_CR6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s00774-013-0520-3","volume":"32","author":"S Tanaka","year":"2014","unstructured":"Tanaka S, Kuroda T, Yamazaki Y, Shiraki Y, Yoshimura N, Shiraki M (2014) Serum 25-hydroxyvitamin D below 25 ng\/mL is a risk factor for long bone fracture comparable to bone mineral density in Japanese postmenopausal women. J Bone Miner Metab 32:514\u2013523","journal-title":"J Bone Miner Metab"},{"key":"982_CR7","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s00198-017-3967-6","volume":"28","author":"J Tamaki","year":"2017","unstructured":"Tamaki J, Iki M, Sato Y, Kajita E, Nishino H, Akiba T, Matsumoto T, Kagamimori S, JPOS Study Group (2017) Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int 28:1903\u20131913","journal-title":"Osteoporos Int"},{"key":"982_CR8","first-page":"658","volume":"30","author":"JF Baker","year":"2012","unstructured":"Baker JF, Baker DG, Toedter G, Shults J, Von Feldt JM, Leonard MB (2012) Associations between vitamin D, disease activity, and clinical response to therapy in rheumatoid arthritis. Clin Exp Rheumatol 30:658\u2013664","journal-title":"Clin Exp Rheumatol"},{"key":"982_CR9","first-page":"745","volume":"28","author":"UJ Haque","year":"2010","unstructured":"Haque UJ, Bartlett SJ (2010) Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clin Exp Rheumatol 28:745\u2013747","journal-title":"Clin Exp Rheumatol"},{"key":"982_CR10","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1002\/art.22722","volume":"56","author":"S Patel","year":"2007","unstructured":"Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D (2007) Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56:2143\u20132149","journal-title":"Arthritis Rheum"},{"key":"982_CR11","doi-asserted-by":"publisher","first-page":"R216","DOI":"10.1186\/ar3195","volume":"12","author":"M Rossini","year":"2010","unstructured":"Rossini M, MaddaliBongi S, La Montagna G, Minisola G, Malavolta N, Bernini L, Cacace E, Sinigaglia L, Di Munno O, Adami S (2010) Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther 12:R216","journal-title":"Arthritis Res Ther"},{"key":"982_CR12","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s10067-013-2216-4","volume":"32","author":"T Furuya","year":"2013","unstructured":"Furuya T, Hosoi T, Tanaka E, Nakajima A, Taniguchi A, Momohara S, Yamanaka H (2013) Prevalence of and factors associated with vitamin D deficiency in 4,793 Japanese patients with rheumatoid arthritis. Clin Rheumatol 32:1081\u20131087","journal-title":"Clin Rheumatol"},{"key":"982_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1080\/14397595.2018.1481727","volume":"29","author":"M Nakayama","year":"2019","unstructured":"Nakayama M, Furuya T, Inoue E, Tanaka E, Ikari K, Nakajima A, Taniguchi A, Yamanaka H (2019) Factors associated with decreasing serum 25(OH)D among Japanese patients with rheumatoid arthritis: results from the IORRA cohort study. Mod Rheumatol 29:430\u2013435","journal-title":"Mod Rheumatol"},{"key":"982_CR14","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00296-010-1393-6","volume":"31","author":"AD Turhanoglu","year":"2011","unstructured":"Turhanoglu AD, Guler H, Yonden Z, Aslan F, Mansuroglu A, Ozer C (2011) The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatol Int 31:911\u2013914","journal-title":"Rheumatol Int"},{"key":"982_CR15","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/acr.21715","volume":"64","author":"UJ Haque","year":"2012","unstructured":"Haque UJ, Bathon JM, Giles JT (2012) Association of vitamin D with cardiometabolic risk factors in rheumatoid arthritis. Arthritis Care Res (Hoboken) 64:1497\u20131504","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"982_CR16","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/acr.21761","volume":"64","author":"J Avouac","year":"2012","unstructured":"Avouac J, Koumakis E, Toth E, Meunier M, Maury E, Kahan A, Cormier C, Allanore Y (2012) Increased risk of osteoporosis and fracture in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Arthritis Care Res (Hoboken) 64:1871\u20131878","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"982_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/14397595.2015.1004276","volume":"25","author":"O Ishida","year":"2015","unstructured":"Ishida O, Furuya T, Inoue E, Ochi K, Ikari K, Taniguchi A, Yamanaka H, Momohara S (2015) Risk factors for established vertebral fractures in Japanese patients with rheumatoid arthritis: results from a large prospective observational cohort study. Mod Rheumatol 25:373\u2013378","journal-title":"Mod Rheumatol"},{"key":"982_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00296-015-3371-5","volume":"36","author":"K Ochi","year":"2016","unstructured":"Ochi K, Furuya T, Ishibashi M, Watanabe M, Ikari K, Taniguchi A, Yamanaka H, Momohara S (2016) Risk factors associated with the occurrence of proximal humerus fractures in patients with rheumatoid arthritis: a custom strategy for preventing proximal humerus fractures. Rheumatol Int 36:213\u2013219","journal-title":"Rheumatol Int"},{"key":"982_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3109\/14397595.2015.1085487","volume":"26","author":"K Ochi","year":"2016","unstructured":"Ochi K, Furuya T, Ikari K, Taniguchi A, Yamanaka H, Momohara S (2016) Association between serum vitamin D level and history of falls in elderly Japanese patients with rheumatoid arthritis. Mod Rheumatol 26:460\u2013462","journal-title":"Mod Rheumatol"},{"key":"982_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266\u2013281","journal-title":"N Engl J Med"},{"key":"982_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12919-018-0102-4","volume":"12","author":"LL Brown","year":"2018","unstructured":"Brown LL, Cohen B, Tabor D, Zappala G, Maruvada P, Coates PM (2018) The vitamin D paradox in Black Americans: a systems-based approach to investigating clinical practice, research, and public health\u2014expert panel meeting report. BMC Proc 12:6","journal-title":"BMC Proc"},{"key":"982_CR22","unstructured":"LeBlanc E, Chou R, Zakher B, Daeges M, Pappas M (2014) Screening for vitamin D deficiency: systematic review for the U. S. Preventive Services Task Force recommendation. Agency for Healthcare Research and Quality (US), Rockville (MD) Nov. Report No.: 13\u201305183-EF-1"},{"key":"982_CR23","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911\u20131930","journal-title":"J Clin Endocrinol Metab"},{"key":"982_CR24","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/art.11465","volume":"49","author":"Y Matsuda","year":"2003","unstructured":"Matsuda Y, Singh G, Yamanaka H, Tanaka E, Urano W, Taniguchi A, Saito T, Hara M, Tomatsu T, Kamatani N (2003) Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis. Arthritis Rheum 49:784\u2013788","journal-title":"Arthritis Rheum"},{"key":"982_CR25","first-page":"714","volume":"30","author":"M Varenna","year":"2012","unstructured":"Varenna M, Manara M, Cantatore FP, Del Puente A, Di Munno O, Malavolta N, Minisola G, Adami S, Sinigaglia L, Rossini M (2012) Determinants and effects of vitamin D supplementation on serum 25-hydroxy-vitamin D levels in patients with rheumatoid arthritis. Clin Exp Rheumatol 30:714\u2013719","journal-title":"Clin Exp Rheumatol"},{"key":"982_CR26","doi-asserted-by":"publisher","first-page":"596007","DOI":"10.3389\/fmed.2020.596007","volume":"7","author":"Y Guan","year":"2020","unstructured":"Guan Y, Hao Y, Guan Y, Bu H, Wang H (2020) The effect of vitamin D supplementation on rheumatoid arthritis patients: a systematic review and meta-analysis. Front Med (Lausanne) 7:596007","journal-title":"Front Med (Lausanne)"},{"key":"982_CR27","first-page":"1056","volume":"36","author":"M Soubrier","year":"2018","unstructured":"Soubrier M, Lambert C, Combe B, Gaudin P, Thomas T, Sibilia J, Dougados M, Dubost JJ (2018) A randomised, double-blind, placebo-controlled study assessing the efficacy of high doses of vitamin D on functional disability in patients with rheumatoid arthritis. Clin Exp Rheumatol 36:1056\u20131060","journal-title":"Clin Exp Rheumatol"},{"key":"982_CR28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/1756-185X.12770","volume":"20","author":"S Chandrashekara","year":"2017","unstructured":"Chandrashekara S, Patted A (2017) Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: an exploratory study. Int J Rheum Dis 20:825\u2013831","journal-title":"Int J Rheum Dis"},{"key":"982_CR29","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00198-015-3184-0","volume":"26","author":"N Yoshimura","year":"2015","unstructured":"Yoshimura N, Muraki S, Oka H, Tanaka S, Kawaguchi H, Nakamura K, Akune T (2015) Factors affecting changes in the serum levels of 25-hydroxyvitamin D: a 3-year follow-up of the ROAD study. Osteoporos Int 26:2597\u20132605","journal-title":"Osteoporos Int"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-021-00982-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-021-00982-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-021-00982-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T15:53:45Z","timestamp":1642089225000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-021-00982-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1007\/s11657-021-00982-x","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,3]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The IORRA study was approved by the Ethical committee of Tokyo Women\u2019s Medical University (No. 2922-R16).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all patients at the time of each survey.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"MN has served on speakers\u2019 bureaus for Asahi Kasei Pharma Corporation, Bristol-Myers Squibb K.K., Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Ono Pharmaceutical Co., Ltd., Shionogi & Co., Ltd. and Takeda Pharmaceutical Co., Ltd. TF has served on speakers\u2019 bureaus for Ayumi Pharmaceutical Co., Ltd., Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd., and Teijin Pharma. EI has received lecture fees from Bristol-Myers Squibb and Pfizer Japan Inc. ET has served on speakers\u2019 bureaus for AbbVie, Ayumi Pharmaceutical Co., Ltd., Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Nippon Kayaku, Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., and UCB Japan Co., Ltd. KI has served on speakers\u2019 bureaus for AbbVie, Astellas Pharma Inc., Asahi Kasei Pharma Corporation, Ayumi Pharmaceutical Co., Ltd., Bristol-Myers Squibb, Eisai Co., Ltd., Chugai Pharmaceutical Co., Ltd., Hisamitsu Pharmaceutical Co., Inc., Janssen Pharmaceutical K.K., Kaken Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Taisho Toyama Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd. HY has received speaker fee from Astellas, Bristol-Meyers-Squibb, Eisai Pfizer, Tanabe-Mitsubishi, Teijin Pharma, and YL Bio. MH has received research grants from AbbVie Japan GK, Asahi Kasei Corp., Astellas Pharma Inc., Ayumi Pharmaceutical Co., Bristol Myers Squibb Co., Ltd., Chugai Pharmaceutical Co., Daiichi-Sankyo, Inc., Eisai Co., Ltd., Kissei Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Nippon Kayaku Co., Ltd., Sekiui Medical, Shionogi & Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd. These sponsors were not involved in the following aspects: study design; collection, analysis, and interpretation of data; writing of the paper; and\/or the decision to submit for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"119"}}